Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
ChinaIPO:
Website:
http://www.ysbiopharm.comNext earnings report:
15 August 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | Mon, 01 Jul 2024 13:30:00 GMTDividend
Analysts recommendations
Institutional Ownership
Included in screeners
What type of business is 331?
LakeShore Biopharma Co., Ltd, a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 2002 and is based in Beijing, China.
What sector is 331 in?
331 is in the Healthcare sector
What industry is 331 in?
331 is in the Biotechnology industry
What country is 331 from?
331 is headquartered in China
What is 331 website?
https://www.ysbiopharm.com
Is 331 in the S&P 500?
No, 331 is not included in the S&P 500 index
Is 331 in the NASDAQ 100?
No, 331 is not included in the NASDAQ 100 index
Is 331 in the Dow Jones?
No, 331 is not included in the Dow Jones index
When does 331 report earnings?
The next expected earnings date for 331 is 15 August 2024